Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues

[1]  E. Havinga,et al.  Vitamin D, example and challenge , 1973, Experientia.

[2]  A. Mouriño,et al.  Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR). , 2003, Organic letters.

[3]  R. Bouillon,et al.  Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs. , 2003, Organic & biomolecular chemistry.

[4]  K. Nilsson,et al.  Synthesis of Tetracyclic Analogues of Calcitriol (1α,25‐Dihydroxyvitamin D3) with Side‐Chain‐Locked Spatial Orientations at C(20) , 2002 .

[5]  L. Sarandeses,et al.  Synthesis of new 18-substituted analogues of calcitriol using a photochemical remote functionalization. , 2002, The Journal of organic chemistry.

[6]  T. Okano,et al.  History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71) , 2001, Steroids.

[7]  D. Moras,et al.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.

[8]  R. Bouillon,et al.  Synthesis of CD-ring modified 1α,25-dihydroxy vitamin D analogues : E-ring analogues , 1996 .

[9]  W. Okamura,et al.  Synthesis of Vitamin D (Calciferol) , 1995 .

[10]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[11]  A. Norman,et al.  14-epi stereoisomers of 25-hydroxy- and 1 alpha,25-dihydroxyvitamin D3: synthesis, isomerization to previtamins, and biological studies. , 1994, Journal of medicinal chemistry.

[12]  L. Snyder,et al.  Synthesis of enantiomerically pure hydrinden-2-ones and benz[e]inden-2-ones via asymmetric alkylations of chiral bicyclic lactams , 1993 .

[13]  R. Bouillon,et al.  Biologic activity of dihydroxylated 19‐nor‐(pre)vitamin D3 , 1993 .

[14]  L. Binderup,et al.  20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. , 1991, Biochemical pharmacology.

[15]  M. Curtin,et al.  Vitamin D (calciferol) and its analogs. 40. 1.alpha.,25-Dihydroxyprevitamin D3: synthesis of the 9,14,19,19,19-pentadeuterio derivative and a kinetic study of its [1,7]-sigmatropic shift to 1.alpha.,25-dihydroxyvitamin D3 , 1991 .

[16]  D. Romo,et al.  Diastereoselective cyclopropanations of chiral bicyclic lactams leading to enantiomerically pure cyclopropanes. Application to the total synthesis of CIS-(1S, 3R)-deltamethrinic acid and R-(-)- dictyopterene C , 1990 .

[17]  H. DeLuca,et al.  1α,25-dihydroxy-19-nor-vitamin D3, a novel vitamin D-related compound with potential therapeutic activity , 1990 .

[18]  G. Posner,et al.  An asymmetric total synthesis of fragrant spiro[4.5]decane sesquiterpene (-)-.beta.-vetivone via an enantiomerically pure vinylic sulfoxide , 1988 .

[19]  E. Abe,et al.  Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia , 1987, FEBS letters.

[20]  T. Mori,et al.  Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues. , 1986, Chemical & pharmaceutical bulletin.

[21]  M. Harré,et al.  Asymmetric synthesis of quaternary carbon centers , 1984 .

[22]  M. Uskoković,et al.  Stereoselective total synthesis of 1.alpha.,25-dihydroxycholecalciferol , 1982 .

[23]  P. Kocieňski,et al.  The influence of chain-branching on the steric outcome of some olefin-forming reactions , 1980 .

[24]  J. L. Cooper,et al.  Stereoselectivity in formation of spiro[5.5]undecanes by cationic .pi. cyclization , 1979 .